KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Other Non-Current Liabilities: 2009-2025

Historic Other Non-Current Liabilities for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $189.5 million.

  • Charles River Laboratories International's Other Non-Current Liabilities fell 19.95% to $189.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.5 million, marking a year-over-year decrease of 19.95%. This contributed to the annual value of $195.2 million for FY2024, which is 12.54% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Other Non-Current Liabilities is $189.5 million, which was up 2.30% from $185.2 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Other Non-Current Liabilities ranged from a high of $242.9 million in Q4 2021 and a low of $172.5 million during Q3 2023.
  • In the last 3 years, Charles River Laboratories International's Other Non-Current Liabilities had a median value of $195.2 million in 2024 and averaged $202.1 million.
  • In the last 5 years, Charles River Laboratories International's Other Non-Current Liabilities declined by 28.02% in 2022 and then skyrocketed by 37.19% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Other Non-Current Liabilities (Quarterly) stood at $242.9 million in 2021, then decreased by 28.02% to $174.8 million in 2022, then increased by 27.67% to $223.2 million in 2023, then decreased by 12.54% to $195.2 million in 2024, then decreased by 19.95% to $189.5 million in 2025.
  • Its Other Non-Current Liabilities stands at $189.5 million for Q3 2025, versus $185.2 million for Q2 2025 and $196.4 million for Q1 2025.